Holdings of Virtus Biotech Etf
ETFis Series Trust I · Original filing · Compare with another fund · Report an error
- Net assets
- 98.5M $ including 98.3M $ in equities, 99.8 %
- Positions
- 67 in 7 countries
- Top ten
- 19.6 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Crinetics Pharmaceuticals Inc | 39,373 | 3.3M $ | 3.34 % |
| 2 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 26,155 | 1.9M $ | 1.97 % |
| 3 | VERASTEM INC | 331,013 | 1.9M $ | 1.95 % |
| 4 | Precigen Inc | 304,977 | 1.9M $ | 1.94 % |
| 5 | OMEROS CORP | 155,369 | 1.8M $ | 1.87 % |
| 6 | Nuvation Bio Inc | 275,843 | 1.7M $ | 1.77 % |
| 7 | Regeneron Pharmaceuticals Inc | 2,218 | 1.7M $ | 1.72 % |
| 8 | Protagonist Therapeutics Inc | 12,363 | 1.7M $ | 1.71 % |
| 9 | ACADIA Pharmaceuticals Inc | 64,350 | 1.7M $ | 1.69 % |
| 10 | Bridgebio Pharma Inc | 20,315 | 1.6M $ | 1.65 % |
| 11 | BEONE MEDICINES LTD | 5,132 | 1.6M $ | 1.65 % |
| 12 | Xeris Biopharma Holdings Inc | 199,875 | 1.6M $ | 1.64 % |
| 13 | Halozyme Therapeutics Inc | 19,528 | 1.6M $ | 1.64 % |
| 14 | Liquidia Corp | 19,053 | 1.6M $ | 1.63 % |
| 15 | Immunocore Holdings PLC | 46,863 | 1.6M $ | 1.61 % |
| 16 | Ironwood Pharmaceuticals Inc | 371,823 | 1.6M $ | 1.60 % |
| 17 | Arrowhead Pharmaceuticals Inc | 18,212 | 1.5M $ | 1.56 % |
| 18 | Roivant Sciences Ltd | 45,179 | 1.5M $ | 1.55 % |
| 19 | Ligand Pharmaceuticals Inc | 5,310 | 1.5M $ | 1.55 % |
| 20 | Rhythm Pharmaceuticals Inc | 15,357 | 1.5M $ | 1.55 % |
| 21 | Geron Corp | 1,180,129 | 1.5M $ | 1.54 % |
| 22 | Rigel Pharmaceuticals Inc | 41,313 | 1.5M $ | 1.54 % |
| 23 | Ascendis Pharma A/S | 6,224 | 1.5M $ | 1.54 % |
| 24 | Arcutis Biotherapeutics Inc | 55,666 | 1.5M $ | 1.52 % |
| 25 | Incyte Corp | 12,506 | 1.5M $ | 1.52 % |
| 26 | CYTOKINETICS INC | 19,346 | 1.5M $ | 1.51 % |
| 27 | MODERNA INC | 27,191 | 1.5M $ | 1.51 % |
| 28 | Amgen Inc | 3,820 | 1.5M $ | 1.49 % |
| 29 | TRAVERE THERAPEUTICS INC | 26,078 | 1.5M $ | 1.48 % |
| 30 | Krystal Biotech Inc | 4,269 | 1.5M $ | 1.48 % |
| 31 | Vertex Pharmaceuticals Inc | 3,052 | 1.5M $ | 1.48 % |
| 32 | BioMarin Pharmaceutical Inc | 24,255 | 1.5M $ | 1.48 % |
| 33 | ZAI LAB LTD | 79,505 | 1.5M $ | 1.47 % |
| 34 | MIRUM PHARMACEUTICALS INC | 13,661 | 1.4M $ | 1.47 % |
| 35 | Denali Therapeutics Inc | 62,658 | 1.4M $ | 1.46 % |
| 36 | TG THERAPEUTICS INC | 27,407 | 1.4M $ | 1.45 % |
| 37 | Neurocrine Biosciences Inc | 8,494 | 1.4M $ | 1.44 % |
| 38 | Syndax Pharmaceuticals Inc | 74,364 | 1.4M $ | 1.44 % |
| 39 | Gilead Sciences Inc | 10,807 | 1.4M $ | 1.43 % |
| 40 | BioCryst Pharmaceuticals Inc | 155,993 | 1.4M $ | 1.42 % |
| 41 | ADMA Biologics Inc | 165,305 | 1.4M $ | 1.42 % |
| 42 | Ultragenyx Pharmaceutical Inc | 55,734 | 1.4M $ | 1.41 % |
| 43 | Harmony Biosciences Holdings Inc | 39,383 | 1.4M $ | 1.41 % |
| 44 | Agios Pharmaceuticals Inc | 46,067 | 1.4M $ | 1.40 % |
| 45 | Biogen Inc | 6,785 | 1.4M $ | 1.40 % |
| 46 | Theravance Biopharma Inc | 81,560 | 1.4M $ | 1.40 % |
| 47 | IMMUNITYBIO INC | 191,148 | 1.4M $ | 1.39 % |
| 48 | Insmed Inc | 13,870 | 1.4M $ | 1.39 % |
| 49 | BioNTech SE | 14,989 | 1.4M $ | 1.38 % |
| 50 | Exelixis Inc | 25,544 | 1.4M $ | 1.37 % |
| 51 | Iovance Biotherapeutics Inc | 332,635 | 1.4M $ | 1.37 % |
| 52 | Kura Oncology Inc | 149,961 | 1.4M $ | 1.37 % |
| 53 | Madrigal Pharmaceuticals Inc | 2,824 | 1.3M $ | 1.34 % |
| 54 | SAREPTA THERAPEUTICS INC | 88,646 | 1.3M $ | 1.34 % |
| 55 | CRISPR Therapeutics AG | 27,251 | 1.3M $ | 1.33 % |
| 56 | Zymeworks Inc | 59,315 | 1.3M $ | 1.32 % |
| 57 | TARSUS PHARMACEUTICALS INC | 21,906 | 1.3M $ | 1.31 % |
| 58 | United Therapeutics Corp | 2,487 | 1.3M $ | 1.31 % |
| 59 | Aurinia Pharmaceuticals Inc | 85,786 | 1.3M $ | 1.30 % |
| 60 | PTC Therapeutics Inc | 18,062 | 1.2M $ | 1.25 % |
| 61 | Ardelyx Inc | 238,515 | 1.2M $ | 1.20 % |
| 62 | Axsome Therapeutics Inc | 5,319 | 1.2M $ | 1.18 % |
| 63 | Phathom Pharmaceuticals Inc | 130,873 | 1.1M $ | 1.16 % |
| 64 | Novavax Inc | 152,832 | 1.1M $ | 1.14 % |
| 65 | ALNYLAM PHARMACEUTICALS INC | 4,798 | 986.1K $ | 1.00 % |
| 66 | IONIS PHARMACEUTICALS INC | 18,522 | 958.9K $ | 0.97 % |
| 67 | LEGEND BIOTECH CORP | 37,834 | 701.8K $ | 0.71 % |
Sector breakdown
- Health care 15.2 %
- Unattributed 84.8 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 90.7 %
- Cayman Islands 2.2 %
- Bermuda 1.6 %
- Denmark 1.5 %
- Germany 1.4 %
- Switzerland 1.3 %
- Canada 1.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 60 | 89.2M $ | 90.70 % |
| 2 | Cayman Islands | 2 | 2.2M $ | 2.19 % |
| 3 | Bermuda | 1 | 1.5M $ | 1.56 % |
| 4 | Denmark | 1 | 1.5M $ | 1.54 % |
| 5 | Germany | 1 | 1.4M $ | 1.38 % |
| 6 | Switzerland | 1 | 1.3M $ | 1.33 % |
| 7 | Canada | 1 | 1.3M $ | 1.30 % |
Cite this page
Titelia. "Holdings of Virtus Biotech Etf". https://titelia.com/en/funds/S000047354